Combination vs. Monotherapy for Stenotrophomonas Maltophilia Infections
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorInstituto de Investigación Sanitaria Gregorio Marañón
About this trial
The goal of this multicentre observational study is to analyse the treatment strategies and the outcomes for patients with S. maltophilia infections using target trial emulation methodology. The main question it aims to answer is:
• Does combined therapy achieve better results than monotherapy in treating S. maltophilia infections?
Researchers will compare groups receiving monotherapy and combined therapy to see if there are differences in all-cause 30-day mortality.
Eligibility criteria
Qualifiers
Adult patients
S. maltophilia infections
Different episodes if a new infection ocurred > 30 days since the index episode
Disqualifiers
isolates obtained from patients outside of hospital admission
microbiological or clinical colonization
hospitalizations shorter than 72 hours since the time zero
patients who died in the first 72 hours since the time zero or who were in imminent risk of death
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov